Use of Fluorescence In Situ Hybridization to Distinguish Metastatic Uveal From Cutaneous Melanoma

被引:5
|
作者
Fang, Yuqiang
Wang, Xuan [2 ]
Dusza, Stephen
Jhanwar, Suresh
Abramson, David
Busam, Klaus J. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA
[2] New York Presbyterian Hosp Weill Cornell, New York, NY USA
关键词
FISH; melanoma; metastasis; MALIGNANT-MELANOMA; BLUE NEVI; MUTATIONS; BRAF; CHROMOSOME-3; SURVIVAL; DISEASE; VEMURAFENIB; LOSSES; GAINS;
D O I
10.1177/1066896912438589
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Metastatic lesions of malignant melanoma can on occasion be difficult to classify with regard to the primary site of origin. Given the lack of specificity of light microscopic features, ancillary studies are needed. In this study, the authors explored the possibility of distinguishing metastatic tumors derived from uveal primaries from those known to have originated from a cutaneous melanoma by fluorescence in situ hybridization (FISH) using probes for chromosome 3, 8q24, and 1p36. A total of 32 metastatic tumors were analyzed by FISH. Monosomy 3 was detected in 9 out of 16 (56.3%) cases of metastatic uveal melanoma but was not found in any of the 16 metastatic cutaneous melanomas (P < .001). With regard to 1p36, amplifications were found in 8 out of 16 (50%) cases of metastatic cutaneous melanoma but not in any case of uveal melanoma (P < .05). 1p36 was deleted in 3 cases of uveal and 1 case of cutaneous melanoma. Amplifications of 8q were found in 15 out of 16 (94%) cases of uveal melanoma metastases and in 12 out of 16 (75%) cases of cutaneous metastases. The findings suggest that FISH for monosomy 3 is a useful adjunct tool in the differential diagnosis of metastatic uveal versus cutaneous melanoma.
引用
收藏
页码:246 / 251
页数:6
相关论文
共 50 条
  • [31] Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry
    Jochems, Anouk
    van der Kooij, Monique K.
    Fiocco, Marta
    Schouwenburg, Maartje G.
    Aarts, Maureen J.
    van Akkooi, Alexander C.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    van den Eertwegh, Alfonsus J. M.
    Franken, Margreet G.
    de Groot, JanWillem B.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Koornstra, Rutger H.
    Kruit, Wim H. J.
    Louwman, Marieke
    Piersma, Djura
    van Rijn, Rozemarijn S.
    Suijkerbuijk, Karijn P. M.
    ten Tije, Albert J.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    van Zeijl, Michiel C. T.
    van der Hoeven, Koos J. M.
    Kapiteijn, Ellen
    CANCERS, 2019, 11 (07)
  • [32] Sensitivity of Fluorescence In Situ Hybridization for Melanoma Diagnosis Using RREBI, MYB, Cep6, and 11q13 Probes in Melanoma Subtypes
    Gerami, Pedram
    Mafee, Mariam
    Lurtsbarapa, Teekay
    Guitart, Joan
    Haghighat, Zahra
    Newman, Marissa
    ARCHIVES OF DERMATOLOGY, 2010, 146 (03) : 273 - 278
  • [33] Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma
    Broman, Kristy K.
    Zager, Jonathan S.
    MELANOMA MANAGEMENT, 2019, 6 (03)
  • [34] Fluorescence In Situ Hybridization Analysis of Atypical Melanocytic Proliferations and Melanoma in Young Patients
    DeMarchis, Emilia H.
    Swetter, Susan M.
    Jennings, Charay D.
    Kim, Jinah
    PEDIATRIC DERMATOLOGY, 2014, 31 (05) : 561 - 569
  • [35] Primary vitreoretinal involvement and immunopositivity for BRAFV600E help distinguish metastatic from primary intraocular melanoma: a detailed histopathologic study of metastatic cutaneous melanoma to the eye
    Neerukonda, Vamsee K.
    Kim, Ivana K.
    Stagner, Anna M.
    HISTOPATHOLOGY, 2022, 80 (07) : 1061 - 1070
  • [36] Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
    Leversha, Margaret A.
    Han, Jialian
    Asgari, Zahra
    Danila, Daniel C.
    Lin, Oscar
    Gonzalez-Espinoza, Rita
    Anand, Aseem
    Lilja, Hans
    Heller, Glenn
    Fleisher, Martin
    Scher, Howard I.
    CLINICAL CANCER RESEARCH, 2009, 15 (06) : 2091 - 2097
  • [37] Fluorescence in situ detection of human cutaneous melanoma:: Study of diagnostic parameters of the method
    Chwirot, BW
    Chwirot, S
    Sypniewska, N
    Michniewicz, Z
    Redzinski, J
    Kurzawski, G
    Ruka, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (06) : 1449 - 1451
  • [38] Primary dermal melanoma: A unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma
    Sidiropoulos, Michael
    Obregon, Roxana
    Cooper, Chelsea
    Sholl, Lauren Meldi
    Guitart, Joan
    Gerami, Pedram
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (06) : 1083 - 1092
  • [39] Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
    Kuk, Deborah
    Shoushtari, Alexander N.
    Barker, Christopher A.
    Panageas, Katherine S.
    Munhoz, Rodrigo R.
    Momtaz, Parisa
    Ariyan, Charlotte E.
    Brady, Mary Sue
    Coit, Daniel G.
    Bogatch, Kita
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Carvajal, Richard D.
    Postow, Michael A.
    ONCOLOGIST, 2016, 21 (07) : 848 - 854
  • [40] Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms
    Reimann, Julie D. R.
    Salim, Sadia
    Velazquez, Elsa F.
    Wang, Lu
    Williams, Kelly Morrissey
    Flejter, Wendy L.
    Brooke, Linda
    Sunder, Sujatha
    Busam, Klaus J.
    MODERN PATHOLOGY, 2018, 31 (11) : 1733 - 1743